PL3250182T3 - Kompozycje dyspergowalne - Google Patents
Kompozycje dyspergowalneInfo
- Publication number
- PL3250182T3 PL3250182T3 PL16701516.3T PL16701516T PL3250182T3 PL 3250182 T3 PL3250182 T3 PL 3250182T3 PL 16701516 T PL16701516 T PL 16701516T PL 3250182 T3 PL3250182 T3 PL 3250182T3
- Authority
- PL
- Poland
- Prior art keywords
- dispersible compositions
- dispersible
- compositions
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Lubricants (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN264MU2015 | 2015-01-27 | ||
| PCT/EP2016/051545 WO2016120258A1 (en) | 2015-01-27 | 2016-01-26 | Dispersible compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3250182T3 true PL3250182T3 (pl) | 2023-07-31 |
Family
ID=55229712
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL16701516.3T PL3250182T3 (pl) | 2015-01-27 | 2016-01-26 | Kompozycje dyspergowalne |
Country Status (29)
| Country | Link |
|---|---|
| US (2) | US20180000810A1 (pl) |
| EP (1) | EP3250182B1 (pl) |
| JP (3) | JP7291458B2 (pl) |
| KR (1) | KR102631986B1 (pl) |
| CN (2) | CN114129526A (pl) |
| AU (2) | AU2016212116B2 (pl) |
| CA (1) | CA2973301A1 (pl) |
| CY (1) | CY1126107T1 (pl) |
| DK (1) | DK3250182T3 (pl) |
| EA (1) | EA201791701A1 (pl) |
| ES (1) | ES2948805T3 (pl) |
| FI (1) | FI3250182T3 (pl) |
| HK (1) | HK1243644A1 (pl) |
| HR (1) | HRP20230616T1 (pl) |
| HU (1) | HUE062481T2 (pl) |
| IL (2) | IL253626B2 (pl) |
| LT (1) | LT3250182T (pl) |
| MA (1) | MA41411B1 (pl) |
| MD (1) | MD3250182T2 (pl) |
| MX (1) | MX2017009681A (pl) |
| PE (1) | PE20171319A1 (pl) |
| PH (1) | PH12017501331A1 (pl) |
| PL (1) | PL3250182T3 (pl) |
| PT (1) | PT3250182T (pl) |
| RS (1) | RS64308B1 (pl) |
| SG (1) | SG11201705944TA (pl) |
| SI (1) | SI3250182T1 (pl) |
| UA (1) | UA126891C2 (pl) |
| WO (1) | WO2016120258A1 (pl) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2937365C (en) | 2016-03-29 | 2018-09-18 | F. Hoffmann-La Roche Ag | Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same |
| RS65207B1 (sr) | 2017-07-14 | 2024-03-29 | Janssen Pharmaceutica Nv | Formulacije bedakvilina sa dugim delovanjem |
| WO2019193609A1 (en) * | 2018-04-05 | 2019-10-10 | Cipla Limited | Pharmaceutical formulations |
| US11291654B2 (en) * | 2018-09-13 | 2022-04-05 | Syneurx International (Taiwan) Corp. | Formulations of cycloserine compounds and applications thereof |
| WO2020123336A1 (en) * | 2018-12-13 | 2020-06-18 | Qrumpharma Inc. | Compositions of bedaquiline, combinations comprising them, processes for their preparation, uses and methods of treatment comprising them |
| JP2022516671A (ja) * | 2019-01-09 | 2022-03-01 | ヤンセン ファーマシューティカ エヌ．ベー． | 非結核性抗酸菌症の処置における組合せ |
| WO2021257461A1 (en) * | 2020-06-15 | 2021-12-23 | Mylan Laboratories Limited | Combination antibacterial composition and method for antibacterial therapy |
| EP4164645A4 (en) * | 2020-06-15 | 2024-07-10 | The Global Alliance For Tb Drug Dev Inc | ANTIBACTERIAL COMBINATION COMPOSITION AND ANTIBACTERIAL THERAPY METHOD |
| CN111888477B (zh) * | 2020-09-15 | 2023-03-07 | 北京福元医药股份有限公司 | 一种贝达喹啉药物制剂 |
| KR102478006B1 (ko) | 2020-12-03 | 2022-12-15 | 정승찬 | 자동차 긴급 제동장치 |
| GB202100470D0 (en) * | 2021-01-14 | 2021-03-03 | Summit Oxford Ltd | Solid tablet dosage for of ridinilazole |
| US11793808B2 (en) | 2021-02-22 | 2023-10-24 | Mannkind Corp. | Compositions of clofazimine, combinations comprising them, processes for their preparation, uses and methods comprising them |
| GB202211231D0 (en) | 2022-08-02 | 2022-09-14 | Glaxosmithkline Ip No 2 Ltd | Novel formulation |
| WO2024130214A2 (en) * | 2022-12-17 | 2024-06-20 | Via Therapeutics, Llc | Clofazimine mini-tablets for treatment of tuberculosis in pediatrics |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4484703B2 (ja) | 2002-07-25 | 2010-06-16 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | キノリン誘導体およびミコバクテリア抑制剤としてのそれらの使用 |
| KR20130024969A (ko) * | 2004-05-28 | 2013-03-08 | 얀센 파마슈티카 엔.브이. | 약물 내성 마이코박테리아 질환 치료를 위한 치환된 퀴놀린 유도체의 용도 |
| EE05394B1 (et) | 2004-12-24 | 2011-04-15 | Janssen Pharmaceutica N.V. | Kinoliinihendid kasutamiseks latentse tuberkuloosi ravis |
| JP5410749B2 (ja) * | 2005-05-25 | 2014-02-05 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | （アルファｓ，ベータｒ）−６−ブロモ−アルファ−［２−（ジメチルアミノ）エチル］−２−メトキシ−アルファ−１−ナフタレニル−ベータ−フェニル−３−キノリンエタノールの製造方法 |
| EE05697B1 (et) * | 2005-06-08 | 2014-02-17 | Janssen Pharmaceutica N.V. | Kinoliini derivaadid kui antibakteriaalsed toimeained |
| UY30535A1 (es) * | 2006-08-10 | 2008-03-31 | Cipla Ltd | Composicion comprendiendo farmacos antirretrovirales y al menos un polimero insoluble en agua, proceso de preparacion y aplicaciones. |
| UA97813C2 (uk) * | 2006-12-05 | 2012-03-26 | Янссен Фармацевтика Н.В. | Фумаратна сіль (альфа s, бета r)-6-бром-альфа-[2-(диметиламіно)етил]-2-метоксі-альфа-1-нафталеніл-бета-феніл-3-хінолінетанолу |
| JO3271B1 (ar) * | 2006-12-06 | 2018-09-16 | Janssen Pharmaceutica Nv | مشتقات الكوينولين المضادة للجراثيم |
| US20110159084A1 (en) * | 2008-04-02 | 2011-06-30 | Dr. Reddy's Laboratories Ltd. | Raloxifene pharmaceutical formulations |
| CA2735229C (en) * | 2008-09-03 | 2014-01-28 | Pfizer Inc. | Combination therapy for tuberculosis |
| US20120207838A1 (en) * | 2011-02-10 | 2012-08-16 | Perricone Nicholas V | Treatment of Psoriasis Using Oral Dosage Forms of Nitrone Spin Traps |
| WO2013153162A1 (en) * | 2012-04-11 | 2013-10-17 | Sandoz Ag | Polymorph of rilpivirine hydrochloride |
| US20140075692A1 (en) * | 2012-09-18 | 2014-03-20 | Unger Marketing International, Llc. | Multiuse cleaning tool handle |
| JP2015537013A (ja) * | 2012-11-19 | 2015-12-24 | アサンタ・アー／エス | 速崩性錠剤 |
-
2016
- 2016-01-26 MA MA41411A patent/MA41411B1/fr unknown
- 2016-01-26 HU HUE16701516A patent/HUE062481T2/hu unknown
- 2016-01-26 JP JP2017557493A patent/JP7291458B2/ja active Active
- 2016-01-26 PE PE2017001255A patent/PE20171319A1/es unknown
- 2016-01-26 IL IL253626A patent/IL253626B2/en unknown
- 2016-01-26 RS RS20230495A patent/RS64308B1/sr unknown
- 2016-01-26 SI SI201631721T patent/SI3250182T1/sl unknown
- 2016-01-26 PL PL16701516.3T patent/PL3250182T3/pl unknown
- 2016-01-26 EA EA201791701A patent/EA201791701A1/ru unknown
- 2016-01-26 CN CN202111218462.7A patent/CN114129526A/zh active Pending
- 2016-01-26 WO PCT/EP2016/051545 patent/WO2016120258A1/en active Application Filing
- 2016-01-26 PT PT167015163T patent/PT3250182T/pt unknown
- 2016-01-26 IL IL310920A patent/IL310920A/en unknown
- 2016-01-26 KR KR1020177023308A patent/KR102631986B1/ko active IP Right Grant
- 2016-01-26 FI FIEP16701516.3T patent/FI3250182T3/fi active
- 2016-01-26 AU AU2016212116A patent/AU2016212116B2/en active Active
- 2016-01-26 EP EP16701516.3A patent/EP3250182B1/en active Active
- 2016-01-26 HR HRP20230616TT patent/HRP20230616T1/hr unknown
- 2016-01-26 SG SG11201705944TA patent/SG11201705944TA/en unknown
- 2016-01-26 CA CA2973301A patent/CA2973301A1/en active Pending
- 2016-01-26 MX MX2017009681A patent/MX2017009681A/es unknown
- 2016-01-26 UA UAA201708632A patent/UA126891C2/uk unknown
- 2016-01-26 LT LTEPPCT/EP2016/051545T patent/LT3250182T/lt unknown
- 2016-01-26 DK DK16701516.3T patent/DK3250182T3/da active
- 2016-01-26 CN CN201680007314.1A patent/CN107205945A/zh active Pending
- 2016-01-26 MD MDE20170303T patent/MD3250182T2/ro unknown
- 2016-01-26 ES ES16701516T patent/ES2948805T3/es active Active
- 2016-01-26 US US15/545,524 patent/US20180000810A1/en not_active Abandoned
-
2017
- 2017-07-21 PH PH12017501331A patent/PH12017501331A1/en unknown
-
2018
- 2018-03-08 HK HK18103261.6A patent/HK1243644A1/zh unknown
-
2021
- 2021-02-12 JP JP2021020595A patent/JP2021098706A/ja active Pending
- 2021-06-21 AU AU2021204135A patent/AU2021204135B2/en active Active
-
2022
- 2022-02-03 US US17/592,097 patent/US20220331307A1/en not_active Abandoned
- 2022-08-22 JP JP2022131578A patent/JP2022176982A/ja active Pending
-
2023
- 2023-07-07 CY CY20231100319T patent/CY1126107T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB202108662D0 (en) | Compositions comprising strains | |
| HK1243644A1 (zh) | 可分散組合物 | |
| SG11201705415YA (en) | Multi-supplement compositions | |
| IL261792B (en) | Preparations | |
| IL260933A (en) | Preparations containing tocorsol or its analogues | |
| IL257131A (en) | Preparations | |
| HK1251559A1 (zh) | 普那布林組合物 | |
| GB201610156D0 (en) | Cliptac compositions | |
| GB201501598D0 (en) | Compositions | |
| GB201515387D0 (en) | Compositions | |
| IL287830A (en) | Prodrug compounds of monomethyl fumarate | |
| GB201515391D0 (en) | Compositions | |
| SI3349766T1 (sl) | Antihemoragični sestavki | |
| GB201614799D0 (en) | Compositions | |
| PL3528791T3 (pl) | Kompozycje dyspergowalne | |
| GB201622161D0 (en) | Compositions | |
| GB2538335B (en) | Compositions | |
| HUE050837T2 (hu) | Készítmények | |
| GB201602658D0 (en) | Compositions | |
| GB201614230D0 (en) | Compositions | |
| GB201611960D0 (en) | Compositions | |
| GB201611851D0 (en) | Compositions | |
| GB201522892D0 (en) | Compositions | |
| GB201602656D0 (en) | Compositions | |
| GB201511469D0 (en) | Compositions |